Category
Childhood cancers
Sub Category
Leukemia
Study Name
AALL1231 A Phase lll Randomized Trial Investigating Bortezomib (NSC#681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Principal Investigator
Renuka Gera, MD
Study Information
Contact for Questions
Neelam Singh 517-364-5591

Site view: at a glance